iTechDachs:
Und ein kurzer Artikel dazu
19.11.18 14:48
Marlborough startup drugmaker RXI Pharmaceuticals now has a runway extending into 2020 as the company continues to reinvent itself and rebrand into a pharmaceutical firm focused on fighting cancer.
Xtrackers MSCI Korea UCITS ETF 1C
Perf. 12M: +140,96%
Xtrackers MSCI Taiwan UCITS ETF 1D
Perf. 12M: +85,82%
Xtrackers MSCI Taiwan UCITS ETF 1C
Perf. 12M: +85,45%
Xtrackers Nikkei 225 UCITS ETF 2D - EUR Hedged
Perf. 12M: +58,90%
Xtrackers MSCI World Value UCITS ETF 1C
Perf. 12M: +56,36%